Shenzhen YHLO Biotech Co., Ltd. (688575.SS)
CNY 14.34
(1.06%)
CNY 14.34
(1.06%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 355.01 Million CNY | -64.92% |
| 2022 | 1.01 Billion CNY | 394.33% |
| 2021 | 204.74 Million CNY | -2.75% |
| 2020 | 210.53 Million CNY | 95.76% |
| 2019 | 107.54 Million CNY | 182.76% |
| 2018 | 38.03 Million CNY | 545.23% |
| 2017 | 5.89 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 106.99 Million CNY | 62.03% |
| 2024 Q1 | 66.03 Million CNY | -5.66% |
| 2024 Q3 | 45.6 Million CNY | -57.37% |
| 2023 Q2 | 60.29 Million CNY | -25.78% |
| 2023 FY | 355.01 Million CNY | -64.92% |
| 2023 Q3 | 143.48 Million CNY | 137.97% |
| 2023 Q1 | 81.23 Million CNY | -41.63% |
| 2023 Q4 | 69.99 Million CNY | -51.21% |
| 2022 Q2 | 154.31 Million CNY | -69.83% |
| 2022 FY | 1.01 Billion CNY | 394.33% |
| 2022 Q4 | 139.17 Million CNY | -32.93% |
| 2022 Q1 | 511.4 Million CNY | 926.96% |
| 2022 Q3 | 207.49 Million CNY | 34.47% |
| 2021 Q1 | 37.66 Million CNY | -38.69% |
| 2021 FY | 204.74 Million CNY | -2.75% |
| 2021 Q4 | 49.79 Million CNY | -24.99% |
| 2021 Q2 | 50.89 Million CNY | 35.13% |
| 2021 Q3 | 66.38 Million CNY | 30.44% |
| 2020 Q2 | 101.39 Million CNY | 14515.32% |
| 2020 Q4 | 61.43 Million CNY | 26.93% |
| 2020 FY | 210.53 Million CNY | 95.76% |
| 2020 Q3 | 48.4 Million CNY | -52.27% |
| 2020 Q1 | -703.41 Thousand CNY | 0.0% |
| 2019 FY | 107.54 Million CNY | 182.76% |
| 2018 FY | 38.03 Million CNY | 545.23% |
| 2017 FY | 5.89 Million CNY | 0.0% |